Summary
Synthesizes RACE Act requirements, FDA pediatric study plans, and pediatric trial outcomes to support pediatric oncology development strategies.
Detailed Description
The Pediatric Oncology Strategy Pack addresses the complex regulatory landscape for pediatric oncology drug development, including the Research to Accelerate Cures and Equity (RACE) for Children Act and Pediatric Research Equity Act (PREA) requirements. It compiles FDA pediatric guidance, the Pediatric Study Plan (PSP) database, and published pediatric oncology trial outcomes.
The pack evaluates your molecular target against the FDA's pediatric molecular target list to determine RACE Act applicability and maps the required pediatric study plan components. It analyzes precedent PSPs and pediatric oncology approvals to identify successful development strategies and common regulatory pitfalls.
Deliverables include a RACE Act applicability assessment, a pediatric study plan template pre-populated with precedent-based recommendations, and a pediatric oncology development timeline aligned with adult program milestones.
Evidence Sources
| Source | Type | Description | Refresh |
|---|---|---|---|
| FDA Pediatric Oncology Guidance | REGULATORY | FDA guidance on RACE Act, PREA requirements, and pediatric oncology drug development | Monthly |
| Pediatric Study Plan Database | REGULATORY | FDA database of submitted and agreed-upon pediatric study plans for oncology products | Quarterly |
| Pediatric Trial Outcomes | REGISTRY | Published results and regulatory outcomes from pediatric oncology clinical trials | Weekly |
Regulatory Mapping
Research to Accelerate Cures and Equity for Children Act
Pediatric Research Equity Act
Pediatric Study Plans: Content of and Process for Submitting Initial Pediatric Study Plans and Amended Initial Pediatric Study Plans
Agent Transparency
When you run this pack, your request is processed by a pipeline of specialized AI agents. Each agent operates with a defined confidence threshold and is auditable end-to-end.
Evidence Retriever
brew-retriever-v3
Queries curated sources for relevant evidence objects. Searches across regulatory databases, clinical registries, and scientific literature to surface the most pertinent references for the pack domain.
Domain Analyzer
brew-domain-analyst-v2
Applies domain-specific reasoning and regulatory mapping. Interprets evidence in the context of FDA, ICH, and EMA frameworks and tags each finding with the relevant guidance references.
Evidence Synthesizer
brew-synthesizer-v2
Synthesizes findings into structured output. Combines retrieved evidence and domain analysis into a cohesive narrative with quantitative summaries, comparative tables, and actionable recommendations.
Output Validator
brew-validator-v1
Validates citations, checks confidence thresholds, and ensures all referenced sources are accessible and correctly attributed. Flags any claims that fall below the confidence floor.
Sample Outputs
RACE Act Applicability Assessment
PDFAssessment of RACE Act obligations based on molecular target analysis and FDA pediatric target list
Pediatric Study Plan Template
DOCXPre-populated PSP template with precedent-based recommendations for study design and endpoints
Pediatric Development Timeline
XLSXIntegrated timeline aligning pediatric development milestones with adult program
Deliverables included
- RACE Act applicability and obligation assessment
- Pediatric Study Plan template with precedent analysis
- Pediatric development timeline and milestone plan
- Pediatric formulation development considerations
- Extrapolation strategy assessment
Related Disease & Biomarker Mappings
| Therapeutic Area | Disease Family | Key Biomarkers | Relevance |
|---|---|---|---|
| Solid Tumors | Non-Small Cell Lung Cancer | EGFRALKPD-L1KRAS G12C | Primary |
| Solid Tumors | Breast Cancer | HER2ER/PRBRCA1/2PIK3CA | Primary |
| Hematologic Malignancies | Acute Myeloid Leukemia | FLT3-ITDIDH1/2NPM1 | Secondary |
| Solid Tumors | Colorectal Cancer | KRAS/NRASBRAF V600EMSI-H/dMMR | Secondary |
Related Packs in Oncology
Oncology Trial Design Pack
Design smarter trials with real-world precedent data
Dose Optimization Pack (Project Optimus)
Navigate the new dose optimization paradigm with confidence
Biomarker-Driven Trial Design Pack
Turn molecular insights into registration-ready trial designs
Immuno-Oncology Combination Pack
Build the regulatory case for your IO combination
Version History
Current release — expanded evidence sources, improved citation accuracy, and added new regulatory cross-references.
Beta release — validated with domain SMEs. Added sample output previews and refined confidence scoring.
Initial draft — core evidence retrieval pipeline and output schema established.
Need a Custom Evidence Pack?
Our enterprise team can build bespoke evidence packs tailored to your therapeutic area, regulatory strategy, or internal decision framework. Custom packs include dedicated evidence source curation, domain-specific agent tuning, and priority SLA support.
Enterprise packs are available for organizations on the BrewBio Pro or Enterprise plan.